好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Developing Neuroprotective Therapies

Monday 04/14/08
07:30 PM - 10:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
After-Dinner Seminar
Paul S. Fishman, MD, PhD
Participants should have a better understanding of the progress and obstacles toward developing effective disease-modifying treatments for neurodegenerative diseases; gain knowledge to help them evaluate the evidence supporting neuroprotective properties of available therapeutics as well as the status of those in development; learn how to counsel patients and families on these issues in an environment of rapidly expanding information; and gain an appreciation of the shared mechanisms, strategies, and obstacles to therapeutic developments in these diverse neurologic conditions.
No CME available
Medical Knowledge
Advanced
Practitioner, Fellow, Academician, Resident, Nurse, Other
Event Timeline
07:30 PM - 08:20 PM Translation Toward Effective ALS Therapies
Robert H. Brown, Jr., MD, DPhil
08:20 PM - 09:10 PM Disease-Modifying Treatments for Alzheimer's Disease
09:10 PM - 09:20 PM Break
09:20 PM - 10:10 PM Neuroprotectants for Parkinson's Disease
Paul S. Fishman, MD, PhD
10:10 PM - 10:30 PM Discussion
Faculty Disclosures
Paul S. Fishman, MD, PhD No disclosure on file
Robert H. Brown, Jr., MD, DPhil Dr. Brown has received personal compensation for serving as an employee of ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Warren Alpert Foundation. Dr. Brown has stock in ApicBio. Dr. Brown has stock in Amylx. Dr. Brown has stock in Imstar. The institution of Dr. Brown has received research support from Angel Fund for ALS Research. The institution of Dr. Brown has received research support from ALS Association. The institution of Dr. Brown has received research support from ALSOne. The institution of Dr. Brown has received research support from NINDS. The institution of Dr. Brown has received research support from ALS Finding A Cure. Dr. Brown has received publishing royalties from a publication relating to health care.